annual D&A:
$81.31M-$3.54M(-4.18%)Summary
- As of today (June 22, 2025), HALO annual depreciation & amortization is $81.31 million, with the most recent change of -$3.54 million (-4.18%) on December 31, 2024.
- During the last 3 years, HALO annual D&A has risen by +$78.31 million (+2613.11%).
- HALO annual D&A is now -4.18% below its all-time high of $84.86 million, reached on December 31, 2023.
Performance
HALO Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$20.45M+$34.00K(+0.17%)Summary
- As of today (June 22, 2025), HALO quarterly depreciation & amortization is $20.45 million, with the most recent change of +$34.00 thousand (+0.17%) on March 31, 2025.
- Over the past year, HALO quarterly D&A has increased by +$243.00 thousand (+1.20%).
- HALO quarterly D&A is now -29.98% below its all-time high of $29.20 million, reached on September 30, 2022.
Performance
HALO quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$81.56M+$243.00K(+0.30%)Summary
- As of today (June 22, 2025), HALO TTM depreciation & amortization is $81.56 million, with the most recent change of +$243.00 thousand (+0.30%) on March 31, 2025.
- Over the past year, HALO TTM D&A has dropped by -$3.05 million (-3.60%).
- HALO TTM D&A is now -3.89% below its all-time high of $84.86 million, reached on December 31, 2023.
Performance
HALO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
HALO Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.2% | +1.2% | -3.6% |
| 3 y3 years | +2613.1% | +2528.4% | +2585.4% |
| 5 y5 years | +1898.8% | +2286.1% | +1972.5% |
HALO Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.2% | +2613.1% | -30.0% | +2528.4% | -3.9% | +2585.4% |
| 5 y | 5-year | -4.2% | +2613.1% | -30.0% | +2682.2% | -3.9% | +2621.2% |
| alltime | all time | -4.2% | >+9999.0% | -30.0% | >+9999.0% | -3.9% | >+9999.0% |
HALO Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $20.45M(+0.2%) | $81.56M(+0.3%) |
| Dec 2024 | $81.31M(-4.2%) | $20.41M(+0.3%) | $81.31M(-0.3%) |
| Sep 2024 | - | $20.36M(+0.1%) | $81.59M(-3.2%) |
| Jun 2024 | - | $20.33M(+0.6%) | $84.31M(-0.4%) |
| Mar 2024 | - | $20.21M(-2.4%) | $84.61M(-0.3%) |
| Dec 2023 | $84.86M(+70.9%) | $20.69M(-10.3%) | $84.86M(+19.1%) |
| Sep 2023 | - | $23.08M(+11.9%) | $71.28M(-7.9%) |
| Jun 2023 | - | $20.63M(+0.8%) | $77.40M(+11.7%) |
| Mar 2023 | - | $20.46M(+187.6%) | $69.32M(+39.6%) |
| Dec 2022 | $49.64M(+1556.4%) | $7.11M(-75.6%) | $49.64M(+14.6%) |
| Sep 2022 | - | $29.20M(+132.8%) | $43.30M(+191.6%) |
| Jun 2022 | - | $12.55M(+1512.6%) | $14.85M(+388.9%) |
| Mar 2022 | - | $778.00K(+0.6%) | $3.04M(+1.3%) |
| Dec 2021 | $3.00M(-8.7%) | $773.00K(+2.9%) | $3.00M(-0.9%) |
| Sep 2021 | - | $751.00K(+2.2%) | $3.02M(-1.7%) |
| Jun 2021 | - | $735.00K(-0.4%) | $3.08M(-2.8%) |
| Mar 2021 | - | $738.00K(-7.8%) | $3.17M(-3.6%) |
| Dec 2020 | $3.28M(-19.3%) | $800.00K(-0.4%) | $3.28M(-6.9%) |
| Sep 2020 | - | $803.00K(-2.5%) | $3.53M(-5.3%) |
| Jun 2020 | - | $824.00K(-3.9%) | $3.73M(-5.3%) |
| Mar 2020 | - | $857.00K(-17.8%) | $3.94M(-3.3%) |
| Dec 2019 | $4.07M(+70.4%) | $1.04M(+4.0%) | $4.07M(+12.5%) |
| Sep 2019 | - | $1.00M(-3.1%) | $3.62M(+12.1%) |
| Jun 2019 | - | $1.03M(+4.4%) | $3.23M(+14.7%) |
| Mar 2019 | - | $990.00K(+67.8%) | $2.81M(+17.8%) |
| Dec 2018 | $2.39M(+10.5%) | $590.00K(-3.6%) | $2.39M(+4.2%) |
| Sep 2018 | - | $612.00K(-1.3%) | $2.29M(+5.3%) |
| Jun 2018 | - | $620.00K(+9.5%) | $2.17M(+2.4%) |
| Mar 2018 | - | $566.00K(+14.8%) | $2.13M(-1.7%) |
| Dec 2017 | $2.16M(-10.3%) | $493.00K(-0.6%) | $2.16M(-6.5%) |
| Sep 2017 | - | $496.00K(-13.0%) | $2.31M(-6.4%) |
| Jun 2017 | - | $570.00K(-5.3%) | $2.47M(-2.1%) |
| Mar 2017 | - | $602.00K(-6.5%) | $2.52M(+4.7%) |
| Dec 2016 | $2.41M(+43.7%) | $644.00K(-1.5%) | $2.41M(+8.3%) |
| Sep 2016 | - | $654.00K(+5.0%) | $2.23M(+12.8%) |
| Jun 2016 | - | $623.00K(+27.4%) | $1.97M(+13.1%) |
| Mar 2016 | - | $489.00K(+6.5%) | $1.75M(+4.1%) |
| Dec 2015 | $1.68M(-4.8%) | $459.00K(+14.2%) | $1.68M(+0.1%) |
| Sep 2015 | - | $402.00K(+1.8%) | $1.68M(-3.6%) |
| Jun 2015 | - | $395.00K(-6.2%) | $1.74M(-2.7%) |
| Mar 2015 | - | $421.00K(-8.1%) | $1.79M(+1.4%) |
| Dec 2014 | $1.76M | $458.00K(-1.3%) | $1.76M(+7.6%) |
| Sep 2014 | - | $464.00K(+4.7%) | $1.64M(+11.1%) |
| Jun 2014 | - | $443.00K(+11.6%) | $1.48M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $397.00K(+18.9%) | $1.33M(+8.3%) |
| Dec 2013 | $1.23M(+13.7%) | $334.00K(+11.0%) | $1.23M(+4.4%) |
| Sep 2013 | - | $301.00K(+1.3%) | $1.18M(+1.3%) |
| Jun 2013 | - | $297.00K(+0.7%) | $1.16M(+2.2%) |
| Mar 2013 | - | $295.00K(+4.3%) | $1.14M(+5.3%) |
| Dec 2012 | $1.08M(-1.5%) | $282.80K(-1.2%) | $1.08M(+3.7%) |
| Sep 2012 | - | $286.20K(+5.1%) | $1.04M(+4.8%) |
| Jun 2012 | - | $272.20K(+14.5%) | $992.90K(-1.4%) |
| Mar 2012 | - | $237.80K(-2.6%) | $1.01M(-8.1%) |
| Dec 2011 | $1.10M(-27.3%) | $244.20K(+2.3%) | $1.10M(-8.3%) |
| Sep 2011 | - | $238.70K(-16.8%) | $1.20M(-9.5%) |
| Jun 2011 | - | $286.80K(-12.1%) | $1.32M(-7.2%) |
| Mar 2011 | - | $326.20K(-5.1%) | $1.42M(-5.6%) |
| Dec 2010 | $1.51M(+4.4%) | $343.80K(-5.7%) | $1.51M(-3.3%) |
| Sep 2010 | - | $364.50K(-6.4%) | $1.56M(-0.3%) |
| Jun 2010 | - | $389.40K(-5.1%) | $1.56M(+2.5%) |
| Mar 2010 | - | $410.30K(+3.8%) | $1.53M(+5.7%) |
| Dec 2009 | $1.44M(+37.8%) | $395.20K(+7.2%) | $1.44M(+7.8%) |
| Sep 2009 | - | $368.50K(+4.9%) | $1.34M(+7.0%) |
| Jun 2009 | - | $351.40K(+6.9%) | $1.25M(+9.0%) |
| Mar 2009 | - | $328.60K(+13.0%) | $1.15M(+9.6%) |
| Dec 2008 | $1.05M(+81.8%) | $290.80K(+3.7%) | $1.05M(+8.0%) |
| Sep 2008 | - | $280.50K(+12.9%) | $970.60K(+15.1%) |
| Jun 2008 | - | $248.40K(+8.9%) | $843.30K(+17.5%) |
| Mar 2008 | - | $228.20K(+6.9%) | $718.00K(+24.6%) |
| Dec 2007 | $576.50K(+136.3%) | $213.50K(+39.4%) | $576.40K(+32.7%) |
| Sep 2007 | - | $153.20K(+24.5%) | $434.20K(+26.2%) |
| Jun 2007 | - | $123.10K(+42.1%) | $344.10K(+23.9%) |
| Mar 2007 | - | $86.60K(+21.5%) | $277.70K(+13.8%) |
| Dec 2006 | $244.00K(+18.3%) | $71.30K(+13.0%) | $244.10K(+8.9%) |
| Sep 2006 | - | $63.10K(+11.3%) | $224.10K(+9.4%) |
| Jun 2006 | - | $56.70K(+7.0%) | $204.90K(-2.1%) |
| Mar 2006 | - | $53.00K(+3.3%) | $209.20K(+1.4%) |
| Dec 2005 | $206.30K(+67.2%) | $51.30K(+16.9%) | $206.30K(+6.2%) |
| Sep 2005 | - | $43.90K(-28.0%) | $194.30K(+6.2%) |
| Jun 2005 | - | $61.00K(+21.8%) | $183.00K(+20.5%) |
| Mar 2005 | - | $50.10K(+27.5%) | $151.90K(+23.2%) |
| Dec 2004 | $123.40K | $39.30K(+20.6%) | $123.30K(+329.6%) |
| Sep 2004 | - | $32.60K(+9.0%) | $28.70K(+71.9%) |
| Jun 2004 | - | $29.90K(+39.1%) | $16.70K(+271.1%) |
| Mar 2004 | - | $21.50K(-138.9%) | $4500.00(+4400.0%) |
| Dec 2003 | - | -$55.30K(-368.4%) | $100.00(-99.8%) |
| Sep 2003 | - | $20.60K(+16.4%) | $55.40K(+59.2%) |
| Jun 2003 | - | $17.70K(+3.5%) | $34.80K(+103.5%) |
| Mar 2003 | - | $17.10K | $17.10K |
FAQ
- What is Halozyme Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual D&A year-on-year change?
- What is Halozyme Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly D&A year-on-year change?
- What is Halozyme Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM D&A year-on-year change?
What is Halozyme Therapeutics annual depreciation & amortization?
The current annual D&A of HALO is $81.31M
What is the all time high annual D&A for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual depreciation & amortization is $84.86M
What is Halozyme Therapeutics annual D&A year-on-year change?
Over the past year, HALO annual depreciation & amortization has changed by -$3.54M (-4.18%)
What is Halozyme Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of HALO is $20.45M
What is the all time high quarterly D&A for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly depreciation & amortization is $29.20M
What is Halozyme Therapeutics quarterly D&A year-on-year change?
Over the past year, HALO quarterly depreciation & amortization has changed by +$243.00K (+1.20%)
What is Halozyme Therapeutics TTM depreciation & amortization?
The current TTM D&A of HALO is $81.56M
What is the all time high TTM D&A for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM depreciation & amortization is $84.86M
What is Halozyme Therapeutics TTM D&A year-on-year change?
Over the past year, HALO TTM depreciation & amortization has changed by -$3.05M (-3.60%)